Evaluating disease progression using magnetic resonance imaging

Abstract

An orthopedic magnetic resonance imaging system is disclosed. This system includes a source of magnetic resonance imaging data sets resulting from successive magnetic resonance imaging acquisitions from a diseased joint of a patient. A segmentation module segments surfaces in the joint based on information contained within at least one of the data sets, and a registration module spatially registers, in three dimensions, information represented by a first of the data sets with respect to information represented by one or more further data sets for the same patient. A comparison module detects differences between information represented by the data sets caused by progression of the disease in the joint of the patient between acquisitions. A cross-patient comparison module can compare detected differences for the patient with detected differences for at least one other patient.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a continuation of U.S. Ser. No. 10 / 430,800, filed May 6, 2003, which is a continuation of U.S. Ser. No. 09 / 704,269, filed Nov. 1, 2000, which claims the benefit of U.S. Provisional Application no. 60 / 162,871, filed Nov. 1, 1999, all of which are herein incorporated by reference.FIELD OF THE INVENTION [0002] This invention relates to methods and apparatus for tracking disease progression using magnetic resonance imaging, including methods and apparatus for efficiently and precisely tracking the progression of rheumatic diseases affecting cartilage. BACKGROUND OF THE INVENTION [0003] Osteoarthritis is a prevalent disease characterized mainly by cartilage degradation that is clinically reflected by a gradual development of joint pain, stiffness, and loss of motion. Osteoarthritis is extremely frequent in the general population, and it is estimated that its radiological prevalence is close to 50% overall. This figure is e...

AI Technical Summary

Benefits of technology

[0037] Systems and methods according to the invention are advantageous in that they can allow precise quantitative tracking of the progression of diseases, such as rheumatic diseases affecting the cartilage. Such precise quantitative tracking can allow for accurate evaluation of the effects of pharmaceutical agents on these diseases in clinical trials. It may also allow physicians to accurately determine how and when to treat individual patients.

[0038] Systems according to the invention may also provide more insight into disease progression. Because they allow physicians to view the effect of disease on different joint structures, systems according to the invention may permit physicians to gain a more detailed insight into the studied disease for a patient or group of patients. This may result in more finely targeted treatment research, or more effectively administered treatment delivery.

[0039] The benefits described above can be provided in a highly efficient manner. Because many aspects of systems and methods according to the invention are extensively automated, little operator intervention is necessary. And because such systems and methods are highly sensitive, relatively short follow-up periods may be achievable. These efficiencies can have a significant impact on the cost of large-scale clinical studies, where many patients must be carefully evaluated. These cost savings may result in the evaluation of a larger number of potential treatments.

Problems solved by technology

Although this disease is often benign, severe degenerative changes may cause serious disability.

Decreased proteoglycan content in conjunction with damaged collagen structure leads to functional loss of normal matrix physiologic properties.

Although the etiology of osteoarthritis is multiple and includes mechanical and biochemical factors, it appears that these culminate in an increased synthesis of proteolytic enzymes by the chondrocytes, which in turn leads to cartilage destruction.

There is no known cure for osteoarthritis, and current treatments are essentially limited to reliving the patient's symptoms.

Unfortunately, evaluating the efficacy of such agents is not an easy, straightforward process.

Simple radiographs are now often used in clinical trials for osteoarthritis to establish inclusion criteria, but such trials have not employed them to assess disease progression.

Arthroscopy appears reliable and sensitive to changes, but it only allows for evaluation of the cartilage surface.

It also appears to be somewhat subjective even when independently trained evaluators review video recordings of the procedures, and, above all, it is invasive.

But the actual application of these proposed systems to the complex problem of making meaningful measurements on acutal diseased joints has not been shown to be entirely successful.

This may be due to one or more of a variety of shortcomings, including extensive manual treatment and interpretation of data, excessive reliance on subjective human judgment, insufficient accuracy or repeatability to achieve meaningful results when used on actual diseased joints, inability to distinguish secondary symptoms, and / or excessively long scan times.

Images